Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and VM (nerve agent): Difference between pages

(Difference between pages)
Page 1
Page 2
Content deleted Content added
Saving copy of the {{chembox}} taken from revid 413451407 of page VM_(nerve_agent) for the Chem/Drugbox validation project (updated: 'CASNo').
 
 
Line 1: Line 1:
{{refimprove|date=March 2018}}
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid [{{fullurl:VM_(nerve_agent)|oldid=413451407}} 413451407] of page [[VM_(nerve_agent)]] with values updated to verified values.}}
{{chembox
{{chembox
| Verifiedfields = changed
| verifiedrevid = 402847770
| Watchedfields = changed
| Name = VM (nerve agent)
| verifiedrevid = 470627428
| Name = VM
| ImageFile = VM-2D-skeletal.png
| ImageFile = VM-2D-skeletal.png
| ImageName = Skeletal formula of VM
| ImageName = Skeletal formula of VM
| ImageFile1 = VM-3D-balls.png
| ImageFile1 = VM-3D-balls.png
| ImageName1 = Ball-and-stick model of VM
| ImageName1 = Ball-and-stick model of VM
| PIN = ''S''-[2-(Diethylamino)ethyl] ''O''-ethyl methylphosphonothioate
| IUPACName = 2-(ethoxy- methylphosphoryl) sulfanyl- N,N-diethylethanamine
| Section1 = {{Chembox Identifiers
| Section1 = {{Chembox Identifiers
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
Line 17: Line 19:
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BKWMHKJLXIRTAI-UHFFFAOYSA-N
| StdInChIKey = BKWMHKJLXIRTAI-UHFFFAOYSA-N
| CASNo_Ref = {{cascite|changed|??}}
| CASNo = <!-- blanked - oldvalue: 21770-86-5 -->
| CASNo = 21770-86-5
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2XM5EU7NUM
| SMILES = O=P(OCC)(SCCN(CC)CC)C
| SMILES = O=P(OCC)(SCCN(CC)CC)C
| PubChem = 30800
| PubChem = 30800
Line 30: Line 35:
}}
}}
}}
}}

'''VM''' ('''Edemo''') is a "V-series" [[nerve agent]] closely related to the better-known [[VX (nerve agent)|VX nerve agent]].<ref name="emergency">{{ cite book | last = Burke | first = R. | title = Counter-Terrorism for Emergency Responders | edition = 2nd | year = 2006 | publisher = CRC Press | isbn = 978-0-8493-9923-7 | page = 94 | doi = 10.1201/9781420009903.fmatt | url = https://books.google.com/books?id=ZavD-EaJy74C&pg=PA94 }}</ref>

Like most of the agents in the V-series (with the exception of VX), VM has not been extensively studied outside of [[military science]]. Little is known about this [[chemical compound]] other than its [[chemical formula]].<ref name="emergency"/>

It is commonly theorized that the so-called "second-generation" V series agents came from a [[Cold War]] era [[Russia]]n [[chemical weapons]] development program. They may have been developed sometime between 1950 and 1990. They have similar [[lethal dose]] levels to VX (between 10 and 50&nbsp;mg) and have similar [[VX (nerve agent)#Symptoms of exposure|symptoms]] and [[method of action]] to other nerve agents that act on [[cholinesterase]]. The treatment remains the same, but the window for effectively treating second generation V series [[seizure]]s is shorter. In addition to the standard seizures, some of the second generation V series agents are known to cause [[coma]]s.<ref name="emergency"/>

==References==
{{reflist}}

{{Chemical warfare}}
{{Acetylcholine metabolism and transport modulators}}

[[Category:Acetylcholinesterase inhibitors]]
[[Category:Diethylamino compounds]]
[[Category:V-series nerve agents]]
[[Category:Phosphonothioates]]
[[Category:Ethyl esters]]


{{organic-compound-stub}}